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ABSTRACT We have previously characterized a monoclonal antibody, $12, that binds only to 
activated platelets (McEver, R. P., and M. N. Martin, 1984, J. Biol. Chem., 259:9799-9804). It
identifies a platelet membrane protein of Mr 140,000, which we have designated as GMP-140. 
Using immunocytochemical techniques we have now localized this protein in unstimulated 
and thrombin-stimulated platelets. Polyclonal antibodies to purified GMP-140 were used to 
enhance the sensitivity of detection. Nonpermeabilized, unstimulated platelets, incubated 
with anti-GMP-140 antibodies, and then with IgG-gold probes, showed very little label for 
GMP-140 along their plasma membranes. In contrast, thrombin-stimulated platelets exhibited 
at least a 50-fold increase in the amount of label along the plasma membrane. On frozen thin 
sections of unstimulated platelets we observed immunogold label along the alpha-granule 
membranes. We also employed the more sensitive technique of permeabilizing with saponin 
unstimulated platelets in suspension, and then incubating the cells with polyclonal anti-GMP- 
140 antibodies and Fab-peroxidase conjugate. Alpha-granule membranes showed heavy 
reaction product, but no other intracellular organelles were specifically labeled. These results 
demonstrate that GMP-140 is an alpha-granule membrane protein that is expressed on the 
platelet plasma membrane during degranulation. 
Activated blood platelets undergo a complex series of bio- 
chemical and morphological changes that promote their he- 
mostatic role at sites of vascular injury. Many of these changes 
occur at the platelet surface. For example, the local generation 
of thrombin stimulates platelet secretion and aggregation, as 
well as fibrin formation (1). The binding of fibrinogen, von 
Willebrand factor, thrombospondin, and fibronectin to the 
surface of the activated platelet promotes cell-cell interactions 
and adhesion of platelets to subendothelial surfaces (2). Factor 
XIIIa binds to thrombin-activated platelets, where it may be 
localized for efficient cross-linking of fibrin polymers into a 
stable clot (3). The molecular events responsible for these 
diverse interactions at the surfaces of activated platelets are 
incompletely defined but thought to involve changes in the 
conformation or rearrangements of platelet membrane gly- 
coproteins. 
We recently described a monoclonal antibody, S12, which 
reacts minimally with unstimulated human platelets but binds 
to -10,000 sites/cell after platelets have been activated with 
thrombin (4). We isolated the protein recognized by S12 by 
affinity chromatography of Lubrol PX-solubilized human 
platelet membranes on S l2-agarose. As analyzed by SDS 
PAGE, the unreduced protein has an Mr of 138,000, and the 
reduced protein has an Mr of 148,000. The slower mobility 
of the reduced protein presumably reflects unfolding of the 
polypeptide after cleavage of intrachain disulfide bonds. The 
molecule appears to be glycosylated, since it stains with peri- 
odic acid-Schiff. 
In our earlier eport (4), we suggested two possible reasons 
for the enhanced binding of S 12 to platelets after thrombin 
activation. The first hypothesis was that the S12-binding 
protein is located in the plasma membrane of unstimulated 
platelets but is inaccessible to antibody. Thrombin activation 
"unmasks" the protein, either by a change in its conformation 
that allows expression of the antigen identified by S12 or by 
rearrangement of other membrane proteins that interfere with 
antibody access to the antigen. The second hypothesis was 
that the protein is localized to a secretory-granule m mbrane 
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that becomes exposed on the platelet surface after thrombin -  
induced secretion from the platelet. We now report the local- 
ization of  the S 12-binding protein in unst imulated and  throm-  
b in-st imulated human platelets by three immunocytochemi -  
cat techniques. Our  data support  the second hypothesis and 
indicate that  the protein is localized exclusively in alpha- 
granule membranes  in the unst imulated platelet. After throm-  
bin st imulat ion and  membrane fusion, the protein is redistri- 
buted to the surface-connected canal icular system (SCCS) 1 
and plasma membrane.  Because of  its distinct localization in 
the unst imulated cell, we have given this protein the desig- 
nat ion GMP-140,  indicat ing that  it is a granule membrane 
protein with a molecular  weight of  ~ 140,000. 
MATERIALS AND METHODS 
Preparation of Antibodies: Purified monoclonal Sl2 lgO was pre- 
pared as previously described (4). Platelet GMP-140, isolated by S12 affinity 
chromatography, was used to raise polyclonal antibodies in rabbits. GMP-140 
was denatured by heating at 100*C for 5 min in the presence of 1% SDS. 
Rabbits were injected subcutaneously with 50 ~g of either nondenatured or
SDS-denatured GMP-140 emulsified in complete Freund's adjuvant. After 4 
wk the rabbits were boosted subcutaneously with 50 ug of the same immunogen 
emulsified in incomplete Freund's adjuvant. They were bled 1 wk later. 
The specificities of the polyclonal antibodies were examined by immuno- 
blotting. 50-ug samples ofplatelet protein, solubilized in 2% SDS in the absence 
of reducing agent, were electrophoresed in parallel lanes of a 7-15% exponential 
polyacrylamide slab gel (5). then transferred to nitrocellulose paper (6). After 
the paper had been immersed in l0 mM NaPO4, 0.15 M NaCI, pH 7.5, 0.05% 
(vol/vol) Tween 20, strips containing individual lanes of separated platelet 
proteins were incubated with nonimmune or immune sera (1:1,000 dilution in 
10 mM NaPO4, 0.15 M NaCI, pH 7.5, 0 05% (vol/vol) Tween 20) for 1 h at
room temperature, th n washed three times with 10 mM NaPO4, 0.15 M NaCI, 
pH 7.5, 0.05% (vol/vol) Tween 20. Bound antibody was then detected with an
enzyme-linked immunosorbent assay system (Vectastain, Vector Laboratories, 
Inc., Burlingame, CA) consisting of sequential additions f biotinylated goat 
anti-rabbit antibody, an avidin-biotinylated horseradish peroxidase complex, 
and a color-developing substrate, 4-chloro-l-napthol. 
Triton X- 1 14 Extraction: Platelet membrane proteins were extracted 
with Triton X-114 as described by Bordier (7). Crude platelet membranes 
prepared by freeze-thawing nd sonication were lysed at 4"C in 10 mM Tris- 
HCI, pH 7.4, 150 mM NaCI, 1 mM EDTA, 1 mM PMSF, 1 mM iodoacetamide, 
1% Triton X-114. After the protein concentration wasadjusted to 0.5 mg/ml, 
the aqueous and detergent phases w re separated (7). The relative amount of 
GMP-140 in each phase wasthen determined by immunoblotting as described 
above, except that bound antibody was detected by incubating the nitrocellulose 
sheet with J2~l-protein A (90,000 cpm/ml). The nitrocellulose was then washed, 
dried, and subjected to autoradiography (4). 
Preparation of Platelets for Immunocytochemical Stud- 
ies: Platelets dripped into fixative were prepared from the blood of normal 
patients as described previously (8). Washed, unstimulated, and thrombin- 
stimulated (1 U/ml for 5 rain) platelets were also prepared as described 
previously (9). EDTA (1 mM) was added to the platelet resuspension buffer to 
minimize cell clumping. Samples were fixed in 2% paraformaldehyde with 
0.05% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 1 h at 37"C. 
Immunocytochemical Procedures: lmmunocytochemical pro- 
cedures on frozen thin sections and on suspensions of nonpermeabilized 
platelets using IgG-colloidal gold (5-nm) probes (Janssen Pharmaceutica, 
Beerse, Belgium) were performed as described previously (8, 9). When sections 
were incubated with polyclonal antibodies, the probe was colloidal gold con- 
jugated with goat anti-rabbit IgG; for sections incubated with monoclonal 
antibody, the probe was colloidal gold conjugated with goat anti-mouse IgG. 
Immunocytochemical procedures on saponin-permeabilized platelets were per- 
formed as previously described (8, 9). 
Control measures for all procedures included the substitution of buffer, 
preimmune rabbit serum, or purified mouse IgG for specific primary antibody. 
RESULTS 
Fig. 1 A i l lustrates the reactivity of  polyclonal ant ibodies pre- 
Abbreviation used in this paper:. SCCS, surface-connected canalicu- 
lar system. 
pared against nondenatured  GMP-140 as assessed by immu-  
noblott ing of  platelet proteins. Similar results were obtained 
with ant ibodies raised against SDS-denatured protein, To 
i l lustrate the specificity of  the ant i -GMP-140 antibodies, im- 
munob lot t ing  was also performed in parallel with ant ibodies 
to GP  l ib, another  membrane glycoprotein, which migrates 
near GMP-140 in SDS gels. Ant ibodies to GMP-140 reacted 
with a single protein of  Mr 140,000, which migrates lightly 
faster than GP  l ib  under  nonreduc ing condit ions. The mo- 
bility of  this protein relative to GP  l ib is identical to that of  
purif ied GMP-140 (4). The monoc lona l  ant ibody S12 also 
reacted with a protein of  identical mobi l i ty in the immuno-  
blott ing procedure (not shown). Therefore, both S12 and the 
polyclonal ant ibodies identify the same molecule. Neither S 12 
nor  the polyclonal ant ibodies bound to GMP-  140 after plate- 
let proteins had been electrophoresed in the presence of  
reducing agent. 
GMP-140 was initially isolated from a Lubrol  (Sigma 
Chemical  Co., St. Louis, MO) -PX  lysate of platelet mem-  
branes (4), which suggests that it is a membrane protein. To 
define further the physical properties of  GMP-140,  we ex- 
tracted platelet membrane proteins at 4"C with Tr i ton X-114 
FIGURE | (A) Immunoblotting of platelet proteins with polyclonal 
ntibodies to GMP-140. SDS extracts of platelets were electropho- 
resed in nonreduced SDS-polyacrylamide gels, transferred to nitro- 
cellulose paper, and incubated with nonimmune or immune sera, 
and bound antibody was detected by an enzyme-linked immuno- 
sorbent assay. Lane I, nonimmune sera; lane 2, anti-glycoprotein 
lib antibodies; lane 3, anti-GMP-140 antibodies. Antibodies to 
GMP-140 reacted with a single protein of Mr 140,000, which mi- 
grates slightly faster than glycoprotein lib under nonreducing con- 
ditions. (B) Evidence for the amphipathic haracter of GMP-140. 
40 pg platelet membrane protein was extracted with Triton X-114. 
The detergent and aqueous phases were recovered and analyzed 
by immunoblotting with anti-GMP-140 antibodies as in A, except 
that ~2Sl-protein A was used to detect bound antibody. Note that 
GMP-140 is markedly enriched in the detergent phase (lane 2) and 
depleted in the aqueous phase (lane 1 ). 
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(7), separated the detergent and aqueous phases at room 
temperature, then analyzed each phase by immunoblotting 
with anti-GMP-140 antibodies. As shown in Fig. 1 B, GMP- 
140 was highly enriched in the detergent phase and depleted 
in the aqueous phase. This indicates that GMP-140 has am- 
phipathic properties and further suggests that it is an integral 
membrane protein. 
In preliminary studies, we determined that the sensitivity 
of immunocytochemical detection of GMP-140 was much 
greater with the polyclonal antibodies than with the monoclo- 
hal antibody S12. This presumably reflects the binding of 
more than one polyclonal antibody to each GMP-140 mole- 
cule or greater affinity of some polyclonal antibody molecules 
for the platelet protein. We have therefore presented the 
polyclonal antibody data, although the S 12 results were iden- 
tical in all cases except for reduced labeling intensity. 
Previous biochemical results (4) indicated that the binding 
of the monoclonal antibody S12 to platelets is dramatically 
enhanced after the platelets have been activated with throm- 
bin. We first investigated this finding morphologically by 
incubating suspensions of nonpermeabilized platelets with 
antibodies to SDS-denatured GMP-140, and comparing the 
labeling with immunogold probes in unstimulated and throm- 
bin-stimulated platelets. Unstimulated platelets, whether im- 
mediately fixed or washed, showed little label on the plasma 
membrane (Fig. 2). Thrombin-stimulated platelets, in con- 
trast, showed at least a 50-fold increase in label on the plasma 
membrane (Fig. 3). Similar results were obtained with anti- 
bodies to nondenatured GMP-140 (not shown). 
We next determined whether the increase in labeling of the 
protein on the platelet surface after thrombin stimulation 
reflected a conformational change in GMP-140, or rearrange- 
ment of other membrane proteins, either of which might 
allow expression ofGMP-140; or the movement of the protein 
from an intracellular location to the plasma membrane. To 
answer this question, we used immunocytochemical proce- 
dures on frozen thin sections of unstimulated platelets, thus 
eliminating the problem of penetration of the cell by immu- 
noreagents. Sections incubated with polyclonal antibodies 
prepared against denatured or nondenatured GMP-140 
showed immunogold label along alpha-granule membranes 
(Fig. 4a). Occasionally the granule membrane bilayer is 
cleaved on frozen thin sections in a manner similar to freeze- 
fractured membranes. When this occurred, we could clearly 
detect he label within the inner granule membrane (Fig. 4 b). 
Other intracellular structures were also labeled (Fig. 4c). 
These structures may be extracted alpha-granules. However, 
since the dense (serotonin-containing) granule cannot be iden- 
tified on frozen sections (8, 9) we cannot rule out the possi- 
bility that its membrane also contains this antigen. Of a total 
of 92 platelets, we observed 73% of the immunogold particles 
over granules, 5% over plasma membrane, and 22% over the 
cell cytoplasm. 
When we used the more sensitive technique of permeabil- 
izing with saponin unstimulated platelets in suspension and 
then incubating the cells with polyclonal antibodies to non- 
denatured GMP-140 and Fab-peroxidase conjugate, we ob- 
served heavy reaction product along many alpha-granule 
membranes (Fig. 4d). No other intracellular organelles were 
specifically labeled; some alpha-granules showed no reaction 
product (Fig. 4 d). 
Since the technique used to examine the localization of 
antigen on thrombin-stimulated platelets did not allow visu- 
alization of internal sites (Fig. 3), frozen thin sections were 
also studied. These sections howed that 5 min after thrombin- 
stimulated egranulation had occurred, most of the GMP- 
140 had been redistributed from the alpha-granule membrane 
to the SCCS and plasma membrane (Fig. 5). 
DISCUSSION 
We have demonstrated by immunocytochemical procedures 
that a glycoprotein detected on the plasma membrane of 
thrombin-stimulated platelets is localized to alpha-granule 
membranes in unstimulated cells. This protein, when electro- 
phoresed on SDS-polyacrylamide g ls in the presence or 
absence of reducing agent, has mobilities similar to those 
previously reported for glycoprotein IIa, a platelet membrane 
protein of unknown function (10, l 1). However, since more 
than one protein may have similar mobilities, depending on 
the gel system employed, we have given this protein (a granule 
membrane protein of Mr 140,000) the designation GMP-140 
to indicate its distinct subeellular localization. GMP-140, 
which is localized in the membrane of alpha-granules, differs 
from secretory proteins uch as fibrinogen and PF4, which 
are packaged within alpha granules (8, 9, 12). Shu-Chun et 
al. have described a monoclonal antibody named KC4, with 
properties imilar to those of Sl2 (13). Subsequent experi- 
ments have indicated that KC4 and S12 identify different 
epitopes on the same platelet protein (Berman, C., B. Furie, 
B. C. Furie, and R. P. McEver, unpublished observations). 
Other investigators have analyzed the protein composition 
of platelet secretory granule, or internal membranes by sub- 
cellular fractionation followed by SDS PAGE or crossed im- 
munoelectrophoresis ( 14-18). Using human platelets, Gogs- 
tad et al. (14, 15) isolated an alpha-granule-rich fraction that 
contained a number of membrane-associated proteins, includ- 
ing two antigens thought to be unique to alpha-granules. Carry 
et al. (19) and Fishkes and Rudnick (20) have identified a 
proton-translocating ATPase in a dense granule fraction from 
porcine platelets, but the enzyme has not been isolated, nor 
FIGURES 2 and 3 Fig. 2: Transmission electron micrograph of washed, unstimulated platelets, fixed and processed immunocy- 
tochemically for the extracellular distribution of GMP-140. Platelets were exposed to anti-GMP-140 polyclonal antibodies 
produced against SDS-denatured GMP-140, and then to immunogold conjugate. Note that there is only a small amount of label 
on the plasma membranes of these cells (arrowheads). Similar results were obtained with antibodies produced against nondena- 
tured GMP-140. x 48,000. Fig. 3: Transmission electron micrograph of thrombin-stimulated (1 U/ml) platelets fixed 5 min after 
thrombin activation and examined immunocytochemically for the extracellular distribution of GMP-140 as in Fig. 2. A large 
amount of immunogold label is observed on the surfaces of these cells (arrowheads) as compared with the unstimulated platelets 
in Fig. 2. Note that the membranes of many vacuolar-appearing structures are also labeled (asterisks). However, since these cells 
have not been permeabilized, these structures must be continuous with the extracellular space, and probably represent dilated 
channels of the SCCS. Other such structures are unlabeled and are probably not yet continuous with the external space. EDTA 
(1 mM) was added to the platelet resuspension buffer to minimize cell clumping after activation with thrombin, x 48,000. 
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FIGURE 4 Frozen thin sections (a-c) of unstimulated platelets exposed to polyclonal antibodies to GMP-140, followed by 
immunogold conjugate. (a) Note the extensive label along alpha-granule membranes (arrowheads). Plasma membrane label is 
insignificant. The apparent cytoplasmic labeling may reflect granule membranes that are obliquely sectioned and not clearly 
visualized, x 70,000. (b) Note immunogold label along the inner granule membrane (arrows) which is cleaved on frozen thin 
sections in a manner similar to freeze-fractured membranes, x 70,000. (c) Label is present along both alpha-granule membranes 
(arrows) and along membranes of, as yet, unidentified structures (arrowheads), which may be a-granules with extracted content 
or dense bodies, x 70,000. (d) Unstimulated platelets, fixed, permeabilized with saponin, and exposed first to polyclonal 
antibodies to nondenatured GMP-140 and then to Fab-peroxidase conjugate. Some granules contain reaction product along their 
membranes (arrowheads), and others are unlabeled, (g) possibly because of incomplete permeabilization of the granule 
membranes by saponin. The matrix of these labeled granules is unreactive: apparently, GMP-140 is confined to the membrane 
of the alpha-granule. The labeled granules are designated as alpha-granules because of their typical size and number. We rarely 
observe dense granules in these frozen thin section preparations. Lysosomes and peroxisomes, which are revealed only by 
specific histochemical stains, are considerably smaller than alpha~granules, gl glycogen; m, mitrochondrion, x 60,000. 
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FIGURE 5 Frozen thin section of thrombin-stimula.ted (I U/ml for 5 min) platelets exposed first to polyclonal antibodies to 
nondenatured GMP-140 and then to immunogold conjugate. By this time, degranulation of the alpha-granules into the SCCS has 
occurred and the center (c) of the cell is now occupied by a dense mass of cytoskeletal elements. Note the extensive label along 
the plasma membranes (arrowheads) and the widened channels of the SCCS (asterisks). x 48,000. 
has SDS PAGE analysis of the dense granule membranes been 
reported. The technique of subcellular fractionation has the 
significant drawback that one membrane fraction may be 
contaminated with another. None of these studies involved 
immunocytochemical analysis: Therefore, we believe that we 
have provided the first well-documented xample of a platelet 
glycoprotein confined to a secretory-granule m mbrane in the 
unstimulated cell. Recently, Buckley and Kelly (21) have 
characterized a transmembrane glycoprotein specific for se- 
cretory vesicles of neural and endocrine cells. 
After platelets have been stimulated with thrombin, GMP- 
140 is redistributed to the SCCS and plasma membrane. We 
showed previously that after thrombin stimulation, alpha- 
granules coalesce, then fuse with membranes ofthe SCCS (8). 
The proteins packaged in the granules are then released to the 
exterior of the cell, where at least some of the molecules bind 
to the platelet surface by Ca++-dependent i teractions (see 
diagram in reference 22). These membrane-bound proteins 
may play important roles in hemostasis (2, 8). Although the 
results reported here were obtained from platelet suspensions 
stimulated with thrombin for 5 min, studies are underway to 
examine shorter periods. This will enable us to determine the 
pattern of GMP-140 redistribution after stimulation from 
early time points to the point of maximal change. At low 
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thrombin concentrations GMP-140 becomes accessible to 
external S12 monoclonal antibody before significant release 
of [t4C]serotonin (4). This is consistent with the observation 
that release of alpha-granule proteins occurs at lower throm- 
bin concentrations than does secretion of dense granule sub- 
stances uch as serotonin (23). GMP-140 presumably redis- 
tributes throughout he SCCS and plasma membranes after 
alpha-granule membranes fuse with SCCS membranes. We 
cannot exclude the possibility that GMP-140 clusters in dis- 
crete regions of the plasma membrane or the SCCS mem- 
branes. Resolution of this question will require immunocy- 
tochemical procedures that allow the visualization of large 
regions of the cell surface. 
Membrane proteins in adrenal chromaffin granules, which 
are exposed on the cell surface after exocytosis, are subse- 
quently internalized, presumably to be recycled into new 
secretory-granule membranes (24-26). Time-course studies of 
washed platelets indicate that the number of S 12 binding sites 
present on the platelet plasma membrane remains constant 
from 10 to 60 min after thrombin stimulation at 37"C 
(George, J. N., and R. P. McEver, unpublished observations). 
This suggests that GMP-140 may not recycle after platelet 
secretion, although we cannot yet exclude such a possibility 
in platelets circulating in vivo. 
The function of this platelet granule membrane protein is 
unknown. Since antibody binding studies indicate that there 
are ~10,000 molecules on the plasma membrane of each 
stimulated cell, GMP-140 appears to be a major component 
of platelet alpha-granule membranes and might play an im- 
portant role in hemostasis. Even platelets from patients with 
the gray platelet syndrome have substantial amounts of im- 
munoreactive GMP-140 (Rosa, J. P., R. P. McEver, and A. 
T. Nurden, unpublished observations). This may be explained 
by recent findings (27) that such platelets contain a population 
of abnormal small alpha-granules that are not identifiable by 
routine transmission electron microscopy. In addition to in- 
vestigating the function of GMP-140, determining its local- 
ization in the human bone marrow megakaryocytes from 
which platelets are derived will be of great interest. Such 
studies may help to identify regions involved in membrane 
protein sorting and organelle formation in these unusual 
polyploid cells. 
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